[Other antimicrobial agents (linezolid, quinupristin/dalfopristin, glycylcycline etc)].
Miyazaki
Shuichi
S
Department of Microbiology, Toho University School of Medicine.
D000081:Acetamides / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D006801:Humans; D000069349:Linezolid; D008911:Minocycline / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D023303:Oxazolidinones / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D013754:Tetracyclines / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D000078304:Tigecycline; D014769:Virginiamycin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology
D000081:Acetamides; D023303:Oxazolidinones; D013754:Tetracyclines; D014769:Virginiamycin; C087533:CL 331002; C113825:quinupristin; D000078304:Tigecycline; D008911:Minocycline; D000069349:Linezolid; C113826:dalfopristin